Global Influenza Vaccine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Influenza Vaccine market size will reach 10,467 Million USD in 2025 and is projected to reach 14,946 Million USD by 2032, with a CAGR of 5.22% (2025-2032). Notably, the China Influenza Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The influenza vaccine, commonly referred to as the flu shot, is a vaccine designed to protect against influenza viruses. It typically contains inactivated or weakened forms of influenza viruses or viral proteins that stimulate the immune system to produce antibodies against the virus. These antibodies help the body recognize and fight off influenza viruses if exposed to them in the future, reducing the severity of illness, complications, and transmission of the flu. Influenza vaccines are recommended for individuals of all ages, especially those at higher risk of developing severe complications from the flu, such as young children, older adults, pregnant women, and individuals with certain medical conditions. Vaccination is typically administered annually, as the influenza virus strains can change from year to year, requiring updated vaccines to provide effective protection against circulating strains. In addition to the standard injectable flu vaccine, there are also nasal spray vaccines available for certain age groups. Vaccination against influenza is a key public health measure for preventing seasonal outbreaks and reducing the burden of influenza-related illness and mortality.
The major global manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Influenza Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Influenza Vaccine Include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Influenza Vaccine Product Segment Include:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Influenza Vaccine Product Application Include:
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Vaccine Industry PESTEL Analysis
Chapter 3: Global Influenza Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Influenza Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Influenza Vaccine market size will reach 10,467 Million USD in 2025 and is projected to reach 14,946 Million USD by 2032, with a CAGR of 5.22% (2025-2032). Notably, the China Influenza Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The influenza vaccine, commonly referred to as the flu shot, is a vaccine designed to protect against influenza viruses. It typically contains inactivated or weakened forms of influenza viruses or viral proteins that stimulate the immune system to produce antibodies against the virus. These antibodies help the body recognize and fight off influenza viruses if exposed to them in the future, reducing the severity of illness, complications, and transmission of the flu. Influenza vaccines are recommended for individuals of all ages, especially those at higher risk of developing severe complications from the flu, such as young children, older adults, pregnant women, and individuals with certain medical conditions. Vaccination is typically administered annually, as the influenza virus strains can change from year to year, requiring updated vaccines to provide effective protection against circulating strains. In addition to the standard injectable flu vaccine, there are also nasal spray vaccines available for certain age groups. Vaccination against influenza is a key public health measure for preventing seasonal outbreaks and reducing the burden of influenza-related illness and mortality.
The major global manufacturers of Influenza Vaccine include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Influenza Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Influenza Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Influenza Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Influenza Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Influenza Vaccine Include:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Influenza Vaccine Product Segment Include:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Influenza Vaccine Product Application Include:
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Influenza Vaccine Industry PESTEL Analysis
Chapter 3: Global Influenza Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Influenza Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Influenza Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Influenza Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Influenza Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Influenza Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Influenza Vaccine Product by Type
- 1.2.1 Trivalent Influenza Vaccine
- 1.2.2 Quadrivalent Influenza Vaccine
- 1.3 Influenza Vaccine Product by Application
- 1.3.1 6 Months to 3 Years
- 1.3.2 ＞ 3 Years
- 1.4 Global Influenza Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Influenza Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Influenza Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Influenza Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Influenza Vaccine Market Development Status and Trends
- 1.5.1 Influenza Vaccine Industry Development Status Analysis
- 1.5.2 Influenza Vaccine Industry Development Trends Analysis
- 2 Influenza Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Influenza Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Influenza Vaccine Market Analysis by Country
- 4.1 Global Influenza Vaccine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Influenza Vaccine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Influenza Vaccine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Influenza Vaccine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Influenza Vaccine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Influenza Vaccine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Influenza Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Influenza Vaccine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Influenza Vaccine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Influenza Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Influenza Vaccine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Influenza Vaccine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Influenza Vaccine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Influenza Vaccine Market Analysis by Type
- 6.1 Global Influenza Vaccine Market Revenue Analysis by Type
- 6.1.1 Global Influenza Vaccine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Influenza Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Influenza Vaccine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Influenza Vaccine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Sanofi
- 7.1.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Sanofi Influenza Vaccine Product Portfolio
- 7.1.3 Sanofi Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 CSL
- 7.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 CSL Influenza Vaccine Product Portfolio
- 7.2.3 CSL Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 GSK
- 7.3.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GSK Influenza Vaccine Product Portfolio
- 7.3.3 GSK Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Viatris
- 7.4.1 Viatris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Viatris Influenza Vaccine Product Portfolio
- 7.4.3 Viatris Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 AstraZeneca
- 7.5.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 AstraZeneca Influenza Vaccine Product Portfolio
- 7.5.3 AstraZeneca Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Hualan Bio
- 7.6.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Hualan Bio Influenza Vaccine Product Portfolio
- 7.6.3 Hualan Bio Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Changchun Institute of Biological
- 7.7.1 Changchun Institute of Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Changchun Institute of Biological Influenza Vaccine Product Portfolio
- 7.7.3 Changchun Institute of Biological Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Sinovac
- 7.8.1 Sinovac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Sinovac Influenza Vaccine Product Portfolio
- 7.8.3 Sinovac Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 BCHT
- 7.9.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 BCHT Influenza Vaccine Product Portfolio
- 7.9.3 BCHT Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Jiangsu GDK
- 7.10.1 Jiangsu GDK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Jiangsu GDK Influenza Vaccine Product Portfolio
- 7.10.3 Jiangsu GDK Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 KM Biologics
- 7.11.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 KM Biologics Influenza Vaccine Product Portfolio
- 7.11.3 KM Biologics Influenza Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Influenza Vaccine Industry Chain Analysis
- 8.2 Influenza Vaccine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Influenza Vaccine Product Downstream Application Analysis
- 8.3.1 Global Influenza Vaccine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Influenza Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Influenza Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Influenza Vaccine Typical Downstream Customers
- 8.5 Influenza Vaccine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
